AU5875799A - Mip-1alpha isoform ld78beta and uses thereof - Google Patents

Mip-1alpha isoform ld78beta and uses thereof

Info

Publication number
AU5875799A
AU5875799A AU58757/99A AU5875799A AU5875799A AU 5875799 A AU5875799 A AU 5875799A AU 58757/99 A AU58757/99 A AU 58757/99A AU 5875799 A AU5875799 A AU 5875799A AU 5875799 A AU5875799 A AU 5875799A
Authority
AU
Australia
Prior art keywords
1alpha
mip
ld78beta
isoform
isoform ld78beta
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU58757/99A
Inventor
Gerard John Graham
Robert John Benjamin Nibbs
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cancer Research Ventures Ltd
Original Assignee
Cancer Research Campaign Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cancer Research Campaign Technology Ltd filed Critical Cancer Research Campaign Technology Ltd
Publication of AU5875799A publication Critical patent/AU5875799A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/523—Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1, LDCF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/642—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the peptide or protein in the drug conjugate being a cytokine, e.g. IL2, chemokine, growth factors or interferons being the inactive part of the conjugate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU58757/99A 1998-09-14 1999-09-14 Mip-1alpha isoform ld78beta and uses thereof Abandoned AU5875799A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9820014.0A GB9820014D0 (en) 1998-09-14 1998-09-14 Receptor antagonists and uses thereof
GB9820014 1998-09-14
PCT/GB1999/003059 WO2000015663A1 (en) 1998-09-14 1999-09-14 MIP-1α ISOFORM LD78β AND USES THEREOF

Publications (1)

Publication Number Publication Date
AU5875799A true AU5875799A (en) 2000-04-03

Family

ID=10838848

Family Applications (1)

Application Number Title Priority Date Filing Date
AU58757/99A Abandoned AU5875799A (en) 1998-09-14 1999-09-14 Mip-1alpha isoform ld78beta and uses thereof

Country Status (3)

Country Link
AU (1) AU5875799A (en)
GB (1) GB9820014D0 (en)
WO (1) WO2000015663A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7235143B2 (en) 2002-08-08 2007-06-26 Praxair S.T. Technology, Inc. Controlled-grain-precious metal sputter targets
CN104013957B (en) 2003-12-23 2016-06-29 泰勒公司 With new anti-il 13 antibodies for treating cancer
WO2006130152A2 (en) * 2004-11-26 2006-12-07 Board Of Regents, University Of Texas System Methods and compositions for correlating ccl3l1/ccr5 genotypes with disorders
CA2803058C (en) 2010-06-25 2022-07-05 Vaccibody As Homodimeric protein constructs
WO2013149186A1 (en) 2012-03-30 2013-10-03 Insulet Corporation Fluid delivery device with transcutaneous access tool, insertion mechansim and blood glucose monitoring for use therewith
NZ756750A (en) 2013-09-13 2022-05-27 Genentech Inc Methods and compositions comprising purified recombinant polypeptides
ES2915378T3 (en) 2013-09-13 2022-06-22 Hoffmann La Roche Methods for detecting and quantifying a host cell protein in cell lines
WO2017091624A1 (en) 2015-11-24 2017-06-01 Insulet Corporation Wearable automated medication delivery system

Also Published As

Publication number Publication date
WO2000015663A1 (en) 2000-03-23
GB9820014D0 (en) 1998-11-04

Similar Documents

Publication Publication Date Title
AU4208799A (en) Interleukins-21 and 22
AU6298699A (en) External material accession systems and methods
AU5560600A (en) Running and testing applications
AU3649199A (en) Sample-holding devices and systems
IL128869A0 (en) Pyrozolopyrimidines and pyrazolotriazines
AU6503299A (en) High-beta-conglycinin products and their use
AU1919295A (en) Aminophospholipid compositions and uses thereof
AU9781998A (en) Huchordin and uses thereof
AU1926000A (en) Pth1r and pth3r receptors
AU2349399A (en) R-lansoprazole compositions and methods
AU4198299A (en) Compounds and uses thereof
AU3753599A (en) Micro-compartmentalization device and uses thereof
AU2660900A (en) 4-haloalkyl-3-heterocyclylpyridines and 4-haloalkyl-5-heterocyclyl-pyrimidines and their use as repellents
AU1037900A (en) Magnetic bearing and its use
AU5091199A (en) Prion protein and uses thereof
AU7659998A (en) N-triazolyl-2-indolecarboxamides and their use as cck-a agonists
AU9301998A (en) Composition and methods using galectin-1
AU5875799A (en) Mip-1alpha isoform ld78beta and uses thereof
AU2333099A (en) Aryloxyanilides and related compounds
AU4629399A (en) Substituted piperazones and their therapeutic uses
AU3086200A (en) Eyesight-correction and/or eye-training device
GB9807586D0 (en) Enzymes and their use
AU3283299A (en) Probiotic composition and the use thereof
AU2669201A (en) Taccalonolides and their use
AU5623599A (en) Aza-cyclodepsipeptides and their use as antiparasitics

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase